Lumexa Imaging (LMRI) vs. Its Rivals Financial Analysis

Lumexa Imaging (NASDAQ:LMRI – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its peers? We will compare Lumexa Imaging to related businesses based on the strength of its valuation, profitability, dividends, institutional ownership, analyst recommendations, risk and earnings.

Profitability

This table compares Lumexa Imaging and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Lumexa Imaging -1.96% -2.93% -0.99%
Lumexa Imaging Competitors -7.86% -135.43% -1.59%

Institutional and Insider Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 0.7% of Lumexa Imaging shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Lumexa Imaging and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Lumexa Imaging $267.73 million -$47.10 million -27.09
Lumexa Imaging Competitors $21.21 billion $301.67 million -1.67

Lumexa Imaging’s peers have higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and target prices for Lumexa Imaging and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lumexa Imaging 1 0 3 2 3.00
Lumexa Imaging Competitors 1881 7755 13405 834 2.55

Lumexa Imaging currently has a consensus target price of $17.60, suggesting a potential upside of 20.30%. As a group, “Healthcare Providers & Services” companies have a potential upside of 15.19%. Given Lumexa Imaging’s stronger consensus rating and higher probable upside, research analysts clearly believe Lumexa Imaging is more favorable than its peers.

Lumexa Imaging Company Profile

(Get Free Report)

Lumexa Imaging operates outpatient diagnostic imaging centers that provide radiology services to patients, referring physicians and healthcare providers. Its services include imaging used to help diagnose and monitor a range of medical conditions. The company offers diagnostic procedures such as MRI, CT, PET/CT, mammography, ultrasound and X-ray through its imaging centers and affiliated radiology practices. Lumexa serves communities across the United States, providing an outpatient option for medical imaging outside of a hospital setting.

Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.